ABUS: Beardsley Robert A reports shares returned to the company
By AlphaYouPublished Form 4
Beardsley Robert A
Reporting filer
Beardsley Robert A reports shares returned to the company, not an open-market purchase or sale, in Arbutus Biopharma Corp. Form 4 filed Oct 7, 2026 lists 1 entry.
- Disclosed
- Oct 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Beardsley Robert A | 2026-10-01 | D | Disposition to issuer | 17948 | 5 | 14,328 | 6 days | Filed terms
|
Common Shares
- Owner
- Beardsley Robert A
- Date
- 2026-10-01
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 17948
- Price
- 5
- Following holdings
- 14,328
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: 0
- transaction Shares: 17948
- id: F1
- transaction Price Per Share: 5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 14328
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Beardsley Robert A: Director.
- F1: Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.